Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Talia Faison"'
Autor:
Thomas G. Biel, Talia Faison, Alicia M. Matthews, Guozhang Zou, Uriel Ortega-Rodriguez, Melissa A. Pegues, Nicole Azer, Fabiola Gomez, Sarah Johnson, Sarah Rogstad, Kang Chen, Hang Xie, Cyrus Agarabi, V. Ashutosh Rao, Tongzhong Ju
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 25, Iss , Pp 124-135 (2022)
Most therapeutic proteins are glycosylated with N-glycans and/or O-glycans. N-glycans on therapeutic proteins have been extensively studied for their control strategy and impact on drug product quality. However, knowledge of O-glycosylation in therap
Externí odkaz:
https://doaj.org/article/512f08e31bf94f93b0d035063e3e0f4d
Autor:
Opeyemi O. Ajayi, Sarah A. Johnson, Talia Faison, Nicole Azer, Jackie L. Cullinan, Jessica Dement-Brown, Scott C. Lute
Publikováno v:
Current Research in Biotechnology, Vol 4, Iss , Pp 190-202 (2022)
Viral contamination is a potential risk of using biotechnology products derived from mammalian cell lines. Therefore, to provide assurance of the safety of these products regarding potential viral contamination, regulatory authorities require viral c
Externí odkaz:
https://doaj.org/article/2cab9ccd68a249e8af8a5986ed6b483d
Autor:
Alicia M Matthews, Thomas G Biel, Uriel Ortega-Rodriguez, Vincent M Falkowski, Xin Bush, Talia Faison, Hang Xie, Cyrus Agarabi, V Ashutosh Rao, Tongzhong Ju
Publikováno v:
PLoS ONE, Vol 17, Iss 12, p e0278294 (2022)
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative agent of the Coronavirus disease 2019 (Covid-19) pandemic, continues to evolve and circulate globally. Current prophylactic and therapeutic countermeasures against Covid-19 i
Externí odkaz:
https://doaj.org/article/9dc8f7e4673040a6ade67c94ecd26dd9
Autor:
Nicole Azer, Nicholas Trunfio, Erica J. Fratz‐Berilla, Jin Sung Hong, Jackie Cullinan, Talia Faison, Cyrus D. Agarabi, David N. Powers
Publikováno v:
Biotechnology Progress.
Autor:
null Nicole Azer, null Nicholas Trunfio, null Erica J. Fratz‐Berilla, null Jin Sung Hong, null Jackie Cullinan, null Talia Faison, null Cyrus D. Agarabi, null David N. Powers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::901347a56680e707d08894746390c2ac
https://doi.org/10.1002/btpr.3347/v2/response1
https://doi.org/10.1002/btpr.3347/v2/response1
Autor:
Thomas G. Biel, Talia Faison, Alicia M. Matthews, Guozhang Zou, Uriel Ortega-Rodriguez, Melissa A. Pegues, Nicole Azer, Fabiola Gomez, Sarah Johnson, Sarah Rogstad, Kang Chen, Hang Xie, Cyrus Agarabi, V. Ashutosh Rao, Tongzhong Ju
Publikováno v:
Molecular therapy. Methodsclinical development. 25
Most therapeutic proteins are glycosylated with N-glycans and/or O-glycans. N-glycans on therapeutic proteins have been extensively studied for their control strategy and impact on drug product quality. However, knowledge of O-glycosylation in therap
Autor:
Sai Rashmika Velugula-Yellela, Scott Lute, Carl Breuning, Sarah A. Johnson, Julie Wang, Matthew R. Brown, Meng-Jung Chiang, Talia Faison, Sherri Dolan, Kurt Brorson, Erica J. Fratz‐Berilla
Publikováno v:
PDA Journal of Pharmaceutical Science and Technology. 74:201-212
Capture bioprocessing unit operations were previously shown to clear or kill several log10 of a model mycoplasma Acholeplasma laidlawii in lab-scale spike/removal studies. Here, we confirm this observation with two additional mollicute species releva
Autor:
Sai Rashmika Velugula-Yellela, Kurt Brorson, Cyrus Agarabi, David N. Powers, Talia Faison, Erica J. Fratz‐Berilla, Casey Kohnhorst
Publikováno v:
Biotechnology and Bioengineering
Mycoplasma contamination events in biomanufacturing facilities can result in loss of production and costly cleanups. Mycoplasma may survive in mammalian cell cultures with only subtle changes to the culture and may penetrate the 0.2 µm filters often
Autor:
Sai Rashmika Velugula-Yellela, David N. Powers, Ryan J. Graham, Nicholas Trunfio, Erica J. Fratz‐Berilla, Adil Mohammad, Cyrus Agarabi, Talia Faison, Casey Kohnhorst, Phillip Angart
Publikováno v:
Biotechnology and Bioengineering
A mycoplasma contamination event in a biomanufacturing facility can result in costly cleanups and potential drug shortages. Mycoplasma may survive in mammalian cell cultures with only subtle changes to the culture and penetrate the standard 0.2‐µm
Autor:
Cyrus Agarabi, Erica J. Fratz‐Berilla, David N. Powers, Talia Faison, Casey Kohnhorst, Phillip Angart, Sai Rashmika Velugula-Yellela, Anneliese Faustino
Publikováno v:
Journal of visualized experiments : JoVE. (147)
Monoclonal antibodies (mAbs) are one of the most popular and well-characterized biological products manufactured today. Most commonly produced using Chinese hamster ovary (CHO) cells, culture and process conditions must be optimized to maximize antib